{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T15:47:22Z","timestamp":1751989642323,"version":"3.40.5"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"MSD Israel in 2012"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.ijcard.2016.02.088","type":"journal-article","created":{"date-parts":[[2016,2,19]],"date-time":"2016-02-19T21:05:32Z","timestamp":1455915932000},"page":"133-138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Association between statin treatment and LDL-cholesterol levels on the rate of ST-elevation myocardial infarction among patients with acute coronary syndromes: ACS Israeli Survey (ACSIS) 2002\u20132010"],"prefix":"10.1016","volume":"210","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9147-4524","authenticated-orcid":false,"given":"Shmuel","family":"Gottlieb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shimon","family":"Kolker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nir","family":"Shlomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shlomi","family":"Matetzky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eran","family":"Leitersdorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amit","family":"Segev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilan","family":"Goldenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Tzivoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giora","family":"Weisz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mady","family":"Moriel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2016.02.088_bb0005","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","article-title":"Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group","volume":"333","author":"Shepherd","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2016.02.088_bb0010","first-page":"1383","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2016.02.088_bb0015","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1161\/01.CIR.97.15.1453","article-title":"Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)","volume":"97","author":"Pedersen","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.02.088_bb0020","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","volume":"360","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2016.02.088_bb0025","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(12)60367-5","article-title":"The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials","volume":"380","author":"Mihaylova","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2016.02.088_bb0030","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.jacc.2014.02.615","article-title":"Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials","volume":"64","author":"Boekholdt","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.02.088_bb0035","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.jacc.2005.04.064","article-title":"Can low-density lipoprotein be too low? The safe and efficacy of achieving very low low-density lipoprotein with intensive statin therapy: a PROVE IT-TIMI 22 substudy","volume":"46","author":"Wiviott","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.02.088_bb0040","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.amjcard.2007.03.102","volume":"100","author":"LaRosa","year":"2007","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.02.088_bb0045","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1016\/j.jacc.2010.09.082","article-title":"Cardiovascular event reduction and adverse events among subjects attaining low-density lipoprotein cholesterol <50mg\/dL with rosuvastatin. The JUPITER trial (Justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin)","volume":"57","author":"Hsia","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.02.088_bb0050","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2016.02.088_bb0055","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel III) final report","volume":"106","author":"National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.02.088_bb0060","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines","volume":"63","author":"Stone","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.02.088_bb0065","article-title":"Contemporary management and attainment of cholesterol targets for patients with dyslipidemia in China","volume":"8","author":"Gao","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2016.02.088_bb0070","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1161\/01.CIR.91.11.2844","article-title":"Molecular bases of the acute coronary syndromes","volume":"91","author":"Libby","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.02.088_bb0075","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel III)","volume":"285","author":"Expert panel on detection evaluation and treatment of high blood cholesterol in adults","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ijcard.2016.02.088_bb0080","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.atherosclerosis.2010.09.005","article-title":"Impact of statin pretreatment on the incidence of plaque rupture in ST-elevation acute myocardial infarction","volume":"213","author":"Otsuka","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ijcard.2016.02.088_bb0085","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-140-11-200406010-00006","article-title":"Association of statin therapy with outcomes of acute coronary syndromes: the GRACE study","volume":"140","author":"Spencer","year":"2004","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijcard.2016.02.088_bb0090","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1159\/000106676","article-title":"The impact of statin treatment on presentation mode and early outcomes in acute coronary syndromes","volume":"109","author":"Cuculi","year":"2008","journal-title":"Cardiology"},{"key":"10.1016\/j.ijcard.2016.02.088_bb0095","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1001\/archinternmed.2010.203","article-title":"Medication in relation to ST-segment elevation myocardial infarction in patients with a first myocardial infarction: Swedish Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA)","volume":"170","author":"Bj\u00f6rck","year":"2010","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ijcard.2016.02.088_bb0100","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.amjmed.2006.09.018","article-title":"Trends in management, hospital and long-term outcomes of elderly patients with acute myocardial infarction","volume":"120","author":"Gottlieb","year":"2007","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ijcard.2016.02.088_bb0105","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jcin.2009.04.016","article-title":"Effect of fluvastatin on progression of coronary atherosclerotic plaque evaluated by virtual histology intravascular ultrasound","volume":"2","author":"Nasu","year":"2009","journal-title":"J. Am. Coll. Cardiol. Intv."},{"key":"10.1016\/j.ijcard.2016.02.088_bb0110","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1016\/j.jacc.2014.08.045","article-title":"Effect of atorvastatin therapy on fibrous cap thickness in coronary atherosclerotic plaque as assessed by optical coherence tomography: the EASY-FIT study","volume":"64","author":"Komukai","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.02.088_bb0115","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.jcin.2009.03.015","article-title":"Effects of statin treatments on coronary plaques assessed by volumetric virtual histology intravascular ultrasound analysis","volume":"2","author":"Hong","year":"2009","journal-title":"J. Am. Coll. Cardiol. Intv."},{"key":"10.1016\/j.ijcard.2016.02.088_bb0120","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1046\/j.1365-2362.2002.01086.x","article-title":"Time-dependent effect of statins on platelet function in hypercholesterolaemia","volume":"32","author":"Puccetti","year":"2002","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.ijcard.2016.02.088_bb0125","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2016.02.088_bb0130","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1056\/NEJMoa1501031","article-title":"Efficacy and safety of alirocumab in reducing lipids and cardiovascular events","volume":"372","author":"Robinson","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2016.02.088_bb0135","doi-asserted-by":"crossref","first-page":"1500-9","DOI":"10.1056\/NEJMoa1500858","article-title":"Open-label Study of Long-term Evaluation against LDL Cholesterol (OSLER) Investigators. Efficacy and safety of evolocumab in reducing lipids and cardiovascular events","volume":"372","author":"Sabatine","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2016.02.088_bb0140","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.jacc.2015.01.036","article-title":"Impact of statins on serial coronary calcification during atheroma progression and regression","volume":"65","author":"Puri","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.02.088_bb0145","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1161\/CIRCULATIONAHA.115.018381","article-title":"Achievement of dual low-density lipoprotein cholesterol and high-sensitivity C-reactive protein targets more frequent with the addition of ezetimibe to simvastatin and associated with better outcomes in IMPROVE-IT","volume":"132","author":"Bohula","year":"2015","journal-title":"Circulation"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316303187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316303187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T16:16:47Z","timestamp":1567613807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527316303187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":29,"alternative-id":["S0167527316303187"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.02.088","relation":{},"ISSN":["0167-5273"],"issn-type":[{"type":"print","value":"0167-5273"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between statin treatment and LDL-cholesterol levels on the rate of ST-elevation myocardial infarction among patients with acute coronary syndromes: ACS Israeli Survey (ACSIS) 2002\u20132010","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.02.088","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}